PHARMA ZEMST
Timeline
47 events since 1983Board
Capital
Filings
Financial
End
Address
198519901995200020052010201520202025
2019
Merger: absorbed by MULTIPHARMADissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares · General meeting of 06-12-20184 points ▸
- General meeting, 06-12-2018
- MULTIPHARMA holds all the shares
- Accounting effect, 01-09-2018
- Power of attorney,
- The deed holds 3 more points.
2018
Merger proposal: to be absorbed by MULTIPHARMA1 point ▸
- Accounting effect, 01-09-2018
- The deed holds 8 more points.
Annual accounts 2017 filed PDFabbreviated format · 14 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 29 days late
2016
Highest result from 2007 to 2017 net €430,865 ▲78.5% The operating result of €674,156 and the net result of €430,865 are both a record.
Liquidity more than doubled current ratio 3.13 The current ratio rises from 1.41 to 3.13.
Equity above €1m equity €1.4m ▲43.2% After 4 profitable years in a row, equity reaches €1.4m.
Registered office moved from Zemst to AnderlechtThe registered office moved from Brusselsesteenweg 128, 1980 Zemst to Square Marie Curie 30 te 1070 Anderlecht · resigns as manager · (manager) and (statutory auditor) appointed · General meeting of 05-12-20169 points ▸
- General meeting, 05-12-2016
- Director resignation, (manager)
- Director discharge, (manager)
- Director appointment, (manager)
- Auditor appointment, (statutory auditor)
- Permanent representative,
- Permanent representative,
- Board meeting, 05-12-2016
- Registered-office move, Square Marie Curie 30 te 1070 Anderlecht
Registered office moved within ZemstThe registered office moved from Brusselsesteenweg 126 A, 1980 Zemst to Brusselsesteenweg 128, 1980 Zemst · General meeting of 01-08-20162 points ▸
- General meeting, 01-08-2016
- Registered-office move, Brusselsesteenweg 128, 1980 Zemst
Annual accounts 2015 filed PDFabbreviated format · 10 days late
2015
New manager appointed, resigned · acts as permanent representative · Director discharge: · General meeting of 03-04-20155 points ▸
- General meeting, 03-04-2015
- Director resignation, (manager)
- Director discharge,
- Director appointment, (manager)
- Permanent representative,
Annual accounts 2014 filed PDFabbreviated format · 27 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 29 days late
2013
Back to profit net €15,677 The net result is €15,677, after one loss-making year.
Annual accounts 2012 filed PDFabbreviated format · 28 days late
2012
Weakest financial year net -€37,996 The net result drops to -€37,996, the lowest from 2007 to 2017.
resigns as manager1 point ▸
- Director resignation, (manager (not named in the articles))
- The deed holds 1 more point.
Annual accounts 2011 filed PDFabbreviated format · 26 days before the deadline
2011
Liquidity more than doubled current ratio 2.12 The current ratio rises from 1.01 to 2.12. Short-term debt falls from €711,794 to €293,411.
Annual accounts 2010 filed PDFabbreviated format · 5 days late
2010
Equity above €500,000 equity €520,971 ▲14.6% With a profit in every financial year since 2007, equity grows to €520,971.
Annual accounts 2009 filed PDFabbreviated format · 1 day before the deadline
2008
Annual accounts 2007 filed PDFabbreviated format · on the deadline day
2007
Annual accounts 2006 filed PDFabbreviated format · 25 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2004
Annual accounts 2004 filed PDFabbreviated format
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
2001
Annual accounts 2000 filed PDFabbreviated format
1999
Annual accounts 1999 filed PDFabbreviated format
1998
Annual accounts 1998 filed NBBabbreviated format
Annual accounts 1997 filed NBBabbreviated format
1996
Annual accounts 1996 filed NBBabbreviated format
1995
Annual accounts 1995 filed NBBabbreviated format
Annual accounts 1994 filed NBBabbreviated format
1994
Annual accounts 1993 filed NBBabbreviated format
1993
Annual accounts 1992 filed NBBabbreviated format
1992
Annual accounts 1991 filed NBBabbreviated format
1991
Annual accounts 1990 filed NBBabbreviated format
1990
Annual accounts 1989 filed NBBabbreviated format
1989
Annual accounts 1988 filed NBBabbreviated format
1988
Annual accounts 1987 filed NBBabbreviated format
1987
Annual accounts 1986 filed NBBabbreviated format
1983
Annual accounts 1983 filed NBBunclassified schema
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
The registered office moved to Zemst in 2016 and to Anderlecht in 2016.12 PHARMA ZEMST has filed 34 sets of annual accounts, the latest for financial year 2017.3 In 2018 the company was absorbed by merger into MULTIPHARMA.4